Introducing Albert Arias, MD
Carilion Clinic and the Virginia Tech Carilion School of Medicine are pleased to welcome Dr. Albert Arias, an addiction psychiatrist and clinical researcher dedicated to advancing precision medicine in the treatment of substance use disorders.
Originally from Michigan, Dr. Arias earned his medical degree from Michigan State University’s College of Human Medicine. He completed his psychiatry residency and later served on the faculty at the University of Connecticut School of Medicine, followed by faculty appointments at Yale School of Medicine and Virginia Commonwealth University School of Medicine.
Dr. Arias has led numerous NIH-funded studies focused on developing and personalizing treatments for addiction. His recent NIAAA-funded R01 trial demonstrated promising results for zonisamide in reducing alcohol use, and his newly awarded NIDA UG3 grant will explore psilocybin-assisted therapy for cocaine use disorder.
With over 15 years of clinical trial and translational research experience, Dr. Arias combines pharmacogenomics, neuroimaging, and artificial intelligence to better understand why treatments work for some patients and not others—bringing psychiatry closer to truly individualized care.